Skip to content
Catalyst

PapersPMID:41315088

Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study.

Diabetologia2026The record ↗

  1. Finding, very limited evidencelowersPostprandial blood glucose area under the curve

What moved

1 findingHow to read these marks →
  • “We found that the iAUC for glucose decreased by 36% (95% CI 14, 57) with KE and 22% (95% CI 1, 44) with KS compared with placebo.”
    Study
    crossover
    Dose studied
    30 g ketone salts, 30 min before a mixed meal test
    Population
    Adults with type 2 diabetes treated with metformin monotherapy or a lifestyle intervention alone; study 1, participant-blind crossover, mixed meal test

Study record

Design
crossover trial
Species
human
Population
Individuals with type 2 diabetes treated with metformin monotherapy or lifestyle intervention alone; study 1 (n=14) compared a ketone monoester (KE), ketone salts (KS; salt form not stated in the abstract) and placebo before a mixed meal; study 2 (n=10) compared KE doses before an OGTT. The ketone monoester is outside this node's boundary; the ketone salts arm is in it (abstract only)
Participants
14
Comparator
placebo
Duration
not reported
Endpoints measured
7